Clinicians in acute or post-acute care settings may delay or avoid serious illness conversations with patients whose cancer prognoses are worsening out of deference to the patient’s oncologist, according to study findings.Researchers conducted 37 semi-structured interviews with physicians and leaders in hospital medicine, oncology, palliative care, home health care and hospice.
Access free, up-to-date clinical guidance on Measles at Healio. We offer valuable insights for identifying, assessing, treating and managing this condition.
Researchers identified barriers nurses encounter when discussing sexual health with patients with prostate cancer, according to an umbrella review
Optimized T-cell manufacturing is one strategy that may prevent SPCs after CAR T-cell therapy, according to Shyam A. Patel, MD, PhD, and Saurabh Dahiya, MD,…
Click on the article title to read more.
Key PointsPegC significantly decreased plasma glutamine and, in combination with Ven, disrupted messenger RNA translation.VenPegC induced complete remissio
Marwan G. Fakih, MD, explains the implications of the findings from the phase 2 trial of balstilimab plus botensilimab for the treatment of patients with…
PURPOSEMobocertinib is an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that targets EGFR exon 20 insertion (ex20ins) mutations in non–small cell lung cancer…
Weiran Feng, Hanzhi Luo and Qing Chen will join Fox Chase Cancer Center as assistant professors. To access this subscriber-only content please log in or…
Findings from the CheckMate 9DW trial support the CHMP’s recommendation for approving nivolumab/ipilimumab for those with unresectable HCC.
What can we help you with today? Close search Livestrong Fertility If you’ve been diagnosed with cancer, we can help alleviate the burden of preserving…
